Uncategorised – Page 8 – Market Industry Forecast News

Men’s Swimwear Market Growth Dynamics: Key Drivers and Restraints

The global men’s Swimwear market size is anticipated to reach USD 7.78 billion by 2030, registering a CAGR of 6.8% from 2024 to 2030, according to a new report by Grand View Research, Inc. Major factor contributing to the market growth includes product innovation as a result of rising demand for fashionable sports apparels. For instance, in 2017, McCartney formed a partnership with ISA Spa to increase the portfolio of their men’s swimwear collection and related products, such as boxers, beach bags, briefs, t-shirts, and towels.

Polyester-based swimwear apparels have the highest demand as they possess excellent strength and UV resistant properties. Furthermore, these products have excellent durability as well as quick drying characteristics. Increasing consumer awareness about advanced fabrics is expected to boost the demand for such products, thereby augmenting market growth. Online distribution channel is expected to be the fastest-growing segment channel over the forecast period.

Access the Men’s Swimwear Market Size, Share & Trends Analysis Report By Fabric (Nylon, Polyester, Spandex, Others), By Distribution Channel (Online, Offline), By Region (North America, APAC, Europe), And Segment Forecasts, 2024 – 2030

Rising penetration of e-commerce websites, such as Myntra and Amazon, which offer a wide range of products at discounted prices and Cash-On-Delivery (COD) services is expected to have a positive impact on the segment growth. Asia Pacific led the global market in 2018 and is projected to expand at the highest CAGR from 2019 to 2025. Changing consumer behavior and growing disposable income levels in developing countries, such as China and India, are the key factors driving the regional market.

Men’s Swimwear Market Report Highlights

The polyester segment held the largest market revenue share of 35.1% in 2023. Attributing to its durability and resistance to wear and tear.

The spandex segment is expected to grow at a significant CAGR over the forecast period. Spandex, known for its superior elasticity and strength, allows for a snug fit that enhances comfort and flexibility during swimming and other water activities.

The offline segment dominated the market with the largest market revenue share in 2023. Offline retail offers customers the opportunity to physically touch and try on products, which is necessary for items like swimwear, where fit and comfort are important.

The online segment is expected to grow at a significant CAGR during the forecast period.

Asia Pacific held the largest market revenue share of 43.44% in 2023. Changing lifestyles and increasing disposable incomes have increased participation in leisure activities such as swimming and beach vacations.

Latin America is anticipated to witness the fastest growth over the forecast period. Latin America’s growing trend towards health and fitness has increased participation in water sports and recreational activities such as swimming and beach-going.

Order your free sample copy of “Men’s Swimwear Market Report 2024 – 2030, published by Grand View Research

Key Men’s Swimwear Company Insights

Some of the key companies in the global men’s swimwear market include Jack Wills; Mr Porter; Male-HQ; Calvin Klein; Topman

Jack Wills provides an eco-friendly mid length swim shorts for men made form more than 95% of recycled polyester featured with an elasticated west band with drawstring for an adjustable fit. It is made from made from sustainably sourced recycled plastic bottle.

Mr Porter with its range of men’s swimwear Orlebar Brown, Vilebrequin, and Polo Ralph Lauren gives a wide range of swimwear which protects from UV radiation and comes in a smarter style and is also available in a printed design options.

Key Men’s Swimwear Companies:

The following are the leading companies in the men’s swimwear market. These companies collectively hold the largest market share and dictate industry trends.

Jack Wills
MR.G’S Designs
Male-HQ
Mr Porter
Marcuse
Calvin Klein
Topman
Helly Hansen
Everlane
Faherty Brand

Recent Developments

In November 2022, Puma Private Equity completed over USD 2 million follow-on investment into Ron Dorff, a premium bodywear brand, in 2020. This investment follows a previous USD 4 million investment in 2020, supporting Ron Dorff’s expansion plans, particularly in the U.S. market. The brand has grown significantly since its inception, with a strong online presence in menswear like swimwear & underwear and a network of global high-end wholesale partners.

About Grand View Research:

Grand View Research, Inc. is a market research and consulting company that provides off-the-shelf, customized research reports and consulting services. To help clients make informed business decisions, we offer market intelligence studies, ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials, and energy. With a deep-seated understanding of varied business environments, Grand View Research provides strategic objective insights. For more information, visit www.grandviewresearch.com

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Email: sales@grandviewresearch.com

Phone:-1-415-349-0058

Bipolar Disorder Market Performance: Evaluating Drug Efficacy and Safety

The global bipolar disorder market is anticipated to reach USD 5.87 billion by 2030, growing at a CAGR of 2.7% from 2024 to 2030, according to a new report by Grand View Research, Inc. Government support for generating awareness about the bipolar disorder and technological advancements that facilitate accurate detection of a patient’s mood and mental state are a few of the factors driving the growth of this market.

The rising prevalence of bipolar disorders is likely to propel market growth in the forecast period. Government initiatives also drive the market growth. For instance, International Bipolar Foundation’s Social Security Disability Insurance (SSDI) or Supplemental Security Income (SSI) are programs offered by the Social Security Administration (U.S.) for the benefit of the people affected by bipolar disorder.

Access the Bipolar Disorder Market Size, Share & Trends Analysis Report By Type (Mood Stabilizer, Anticonvulsants, Antipsychotic Drugs), By Drug Class, By Distribution Channel, By Region, And Segment Forecasts, 2024 – 2030

Besides, technological advancements in smartphones, smartwatches, and wearable devices improve diagnosis rates by capturing physiological, behavioral, and environmental data effectively to detect the patient’s mood and mental state. Online self-management tools also result in timely intervention, thereby improving diagnosis rates and treatment rates for the disorder. However, the patent expiry of blockbuster drugs in this market is likely to impact market dynamics in the forecast period. Additionally, the drugs in the bipolar disorder market are bound to face intense competition from generic drugs, as treatment options for bipolar disorder. Other factors likely to restrain market growth in the forecast period include side effects associated with bipolar drugs, and misdiagnosis of bipolar disorder.

Bipolar Disorder Market Report Highlights

The mood stabilizer segment dominated the market in 2023, with a share of 35.0% in 2023 due to the rising prevalence of bipolar disorder.

The selective serotonin reuptake inhibitor segment dominated the market in 2023, with a share of 25.0%. The factors responsible for the market growth are the efficacy and safety profile of selective serotonin reuptake inhibitors (SSRIs), which are effective in managing the depressive symptoms occurring due to bipolar disorder.

The hospital pharmacies segment dominated the market in 2023, with a share of 49.8% in 2023. This market growth was attributed to the increase in the number of patients seeking a diagnosis of their mental health.

North America dominated the bipolar disorder market with a market share of 39.4% in 2023. This was attributed to the increase in the cases of bipolar disorders and the presence of significant medical institutes in the region.

Order your free sample copy of “Bipolar Disorder Market Report 2024 – 2030, published by Grand View Research

Key Bipolar Disorder Company Insights

Some of the major companies in the global bipolar disorder market are AstraZeneca, Eli Lilly and Company, GSK plc, Johnson & Johnson Services, Inc., Pfizer, Inc. Companies are focusing on developing medicines and therapies in order to target various type of cancers. Companies are also focusing on reducing the side effects of medicines and treatments involved in treating bipolar disorders.

Pfizer, Inc. is a pharmaceutical and biomedical company, specializing in the research, production, and promotion of medications and vaccines for both people and animals. Pfizer collaborates with health care providers, governments and local communities to support and expand access to health care around the world.

AstraZeneca plc is a pharmaceutical and biotechnology company, which offers products for various major diseases such as oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation.

Key Bipolar Disorder Companies:

The following are the leading companies in the bipolar disorder market. These companies collectively hold the largest market share and dictate industry trends.

AstraZeneca
Eli Lilly and Company
GSK plc
Johnson & Johnson Services, Inc
Pfizer Inc.
AbbVie Inc.
Otsuka Holdings Co., Ltd.
Bristol-Myers Squibb Company
Teva Pharmaceutical Industries Ltd.
Sumitomo Pharma America, Inc.

Recent Developments

In December 2023, Bristol-Myers Squibb Company acquired Karuna Therapeutics, a biopharmaceutical company that develops medicines related to psychiatric and neurological conditions. This acquisition strengthened the neuroscience portfolio of Bristol-Myers Squibb Company.

About Grand View Research:

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone:-1-415-349-0058

Email: sales@grandviewresearch.com

Targeted DNA RNA Sequencing Market Forecast: Anticipating Changes in Consumer Preferences

The global targeted DNA RNA sequencing market size is expected to reach USD 34.56 billion in 2030 and is projected to grow at a CAGR of 19.4% from 2024 to 2030. Targeted Sequencing has emerged as a key technology in life science research by enabling examination of a specific region of interest while keeping the seq. cost as well as the complexity of data under manageable limits.

This approach enhances sequencing depth by allowing the evaluation of specific coding regions within genes or specific genes, which are known to harbor mutations for disease pathogenesis. Several research projects have employed this technology to avoid wastage of information and extra cost and study only relevant genes. The number of such projects continues to grow, consequently driving the market.

Innovations to address the pitfalls of targeted enrichment methods are anticipated to enhance the usage rate of this technology throughout the forecast period. Moreover, with a decrease in seq-cost and improvement in informatics, targeted methods have become more accessible for use in clinical settings than ever.

Access the Targeted DNA RNA Sequencing Market Size, Share & Trends Analysis Report By Product (NGS), By Workflow (Pre-sequencing), By Application, By Technology, By Type, By End Use, And Segment Forecasts, 2024 – 2030

Targeted DNA RNA Sequencing Market Report Highlights

Rapid advancements in NGS and its ancillary protocols can be attributed to the growth of this segment.

Out of all the NGS-based targeted methods, exome-seq held the largest share.

This can be attributed to the fact that though it accounts for less than 2% of the genome, it contains 85% of the known disease-relevant variants.

Entire targeted approach is broken down into presequencing, sequence determination, and data analysis.

Being the most crucial step, sequencing accounted for the largest share.

This space has revolutionized various applications of life sciences, including human biomedical research, plant & animal sciences, drug discovery, and others.

Out of all, human biomedical research is estimated to be the largest application of this space due to its high usage in studying disease pathogenesis.

The targeted DNA/RNA sequencing market is bifurcated into DNA-seq and RNA-seq, based on the sample type.

DNA-sequencing has been estimated to generate higher revenue over its counterpart segment. This can be attributed to the presence of a wide range of products and kits for DNA-seq.

As per end use, academic research is estimated to be the largest segment owing to the increase in seq-based projects at universities and other academic centers.

North America held the largest share owing to the presence of effective regulations pertaining to approval of genetic tests and bioinformatics tools.

Moreover, the U.S. is observed to have the highest number of installed sequencers, which in turn, has contributed to the large share of the North America regional market.

Asia Pacific is expected to emerge as the fastest growing regional market.

Rise in genome-based projects coupled with constant GDP growth in Asian countries is expected to drive the Asia Pacific market.

Key Targeted DNA RNA Sequencing Company Insights

Some key companies in the global targeted DNA RNA sequencing market include Illumina, F. Hoffman La-Roche Ltd, QIAGEN, Bio-Rad Laboratories, and others. Vendors in the market are focusing on increasing their customer base to gain a competitive edge in the industry. Therefore, key players undertake several strategic initiatives, such as mergers, acquisitions, and partnerships with other major companies.

Illumina is among the world’s foremost makers of genomic equipment including DNA sequencing and microarray technology. Their products assist researchers and healthcare providers with information that can be used to diagnose diseases, develop individualized treatments, and progress various scientific disciplines related to genetics.

Roche is a leading healthcare company, dedicated to research and innovation in pharmaceutical and diagnostic products. They own leading clinical products in oncology, immunology, and diagnostic products for personalized medicine.

Order your free sample copy of “Targeted DNA RNA Sequencing Market Report 2024 – 2030, published by Grand View Research

Key Targeted DNA RNA Sequencing Companies:

The following are the leading companies in the targeted DNA RNA sequencing market. These companies collectively hold the largest market share and dictate industry trends.

Illumina
F. Hoffman-La Roche Ltd.
QIAGEN
Thermo Fisher Scientific, Inc.
Bio-Rad Laboratories, Inc.
Oxford Nanopore Technologies
PierianDx
Genomatix GmbH
DNASTAR, Inc.
Perkin Elmer, Inc.

Recent Developments

In June 2024, Bio-Rad launched a new ddSEQ Single-Cell 3′ RNA-Seq Kit to support single-cell gene expression research. This kit enables researchers to affordably and rapidly analyze gene expression on the single-cell resolution. It is anticipated that this technology will help in the research of oncology, immunology, and more.

In May 2024, a new paper was published in Genomic Medicine highlighting global efforts to increase access to genome sequencing for diagnosing rare genetic disorders and focusing on its potential to improve diagnosis speed and reduce healthcare costs. The Medical Genome Initiative calls for broader insurance coverage, reduced administrative barriers, and increased clinician education to support the widespread adoption of genome sequencing.

About Grand View Research:

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone:-1-415-349-0058

Email: sales@grandviewresearch.com

Riding Boots Market Expansion: Focus on Customization and Personalized Fit Options

The global riding boots market size is expected to reach USD 2.42 billion by 2030, registering a CAGR of 5.9% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing enthusiasm for cruiser, sport, and dirt bikes for long road trips and adventurous off-roading is expected to be a key growth driver. Rising road safety awareness in order to prevent road traffic crashes is anticipated to drive the market demand for various safety gear including riding boots.

Stringent government policies to encourage motorcycle safety and adoption of safety gear, such as riding shoes for riders as well as pillions are expected to positively influence the market growth. The rising incidence of road crashes is one of the major challenges for governments and authorities. The introduction of effective and sustainable safety solutions for such accidents is expected to further drive product demand. According to the Global Status Report on Road Safety 2018, published by the World Health Organization (WHO), in 2016, 1.35 million people lost lives in various motorbike and road traffic accidents. Rising awareness regarding rider safety is expected to drive the bike shoes market over the forecast period.

Sport and race boots was the largest product segment in the market, with a share of more than 60% in 2018 and is anticipated to continue its dominance during the forecast period. Key manufacturers offer innovative boots, developed from composites materials for utmost safety and comfort. For instance, in July 2018, Alpinestars S.p.A launched the newest series of riding gears including riding boots called Tech 10. These boots are designed using the latest Front Flexion Control Frame technology with a resigned foot shell and slimmer outsole. According to the company, the new buckles added to the footwear are durable and better to operate. Such product launches are anticipated to boost the bike gear market over the forecast period.

Access the Riding Boots Market Size, Share & Trends Analysis Report By Product, (Sports & Race Boot, Cruising & Touring Boot, Adventure & Dual Sport Boot), By Distribution Channel, By Region, And Segment Forecasts, 2024 – 2030

Europe was the largest market, with a share of more than 30.0% in 2018. The strong foothold of the largest sports bike manufacturers including Ducati, Aprilia, Benelli, and Cagiva is expected to ensure the continuous popularity of motorcycling in Europe and thus, in turn, will expand the scope of riding footwear over the next few years. Key product manufacturers, such as Alpinestars S.p.A, LeMans Corporation, Dainese S.p.A, FOX, FLY Racing, and TCX S.r.l., focus on launching new products to gain a greater consumer base.

Riding Boots Market Report Highlights

The Asia Pacific riding boots is anticipated to register the fastest CAGR over the forecast period. The growing affluence and urbanization in the Asia Pacific contribute to expanding the riding boots market

The cruising & touring boots segment is expected to register the fastest CAGR of 6.2% during the forecast period owing to the rising popularity of long road trips as a recreational activity

The online distribution channel is expected to register the fastest CAGR during the forecast period, as these channels offer a high level of convenience to the consumers

Key Riding Boots Company Insights

Some of the key companies in the global riding boots market include Alpinestars S.p.A, LeMans Corporation, Dainese S.p.A, FOX, FLY Racing, and GAERNE USA. Organizations are focusing on increasing customer base to gain a competitive edge in the industry. Therefore, key players are taking several strategic initiatives.

Alpinestars S.p.A is an Italian manufacturer of safety equipment for motorsports and action sports. They offer a wide range of specialized products for various motorsports and outdoor activities, including MotoGP, motocross, motorcycling, Formula One, World Rally Championship, WEC, V8 Supercars, and NASCAR. Additionally, the company provides custom riding boots for various riders and activities.

LeMans Corporation provides a diverse selection of riding boots designed to meet the demands of different riding styles and preferences. Their riding boots are crafted with high-quality materials to ensure durability, comfort, and protection for riders.

Order your free sample copy of “Riding Boots Market Report 2024 – 2030, published by Grand View Research

Key Riding Boots Companies:

The following are the leading companies in the riding boots market. These companies collectively hold the largest market share and dictate industry trends.

Alpinestars S.p.A
LeMans Corporation
Dainese S.p.A
FOX
FLY Racing
Gaerne Spa
TCX S.r.l.
Horze
Parlanti Roma
Tattini Boots

Recent Developments

In March 2023, Gaerne Spa launched the new Gaerne SG.22 Off-Road boots for the motocross and enduro riding community. These boots boast a range of innovative features and endorsements from top riders and teams. It incorporates the Gaerne Dual Stage Pivot System 1.0, which provides ankle support with two limit switches to effectively limit hyperflexion, hyperextension, and lateral movements.

About Grand View Research:

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone:-1-415-349-0058

Email: sales@grandviewresearch.com

Residential Lighting Fixtures Market Report: Impact of COVID-19 on Industry Recovery

The global residential lighting fixtures market size is expected to reach USD 22.41 billion by 2030, expanding at a CAGR of 6.4% from 2024 to 2030, according to a new report by Grand View Research, Inc. The rapid replacement of traditional lights with more energy-efficient and economical lighting fixtures is expected to remain a prominent trend. Furthermore, rising middle-class population in developing countries including China, India, Bangladesh, and Philippines as a result of urban development and increasing number of employment opportunities is projected to have a positive impact on the market.

The Light-emitting Diodes and Organic Light-emitting Diode (LED & OLED) led the market in 2018, contributing to over 50% of revenue share. High energy-efficiency and durability is anticipated to drive the growth. This segment is expected to witness steady growth in the upcoming years owing to the implementation of government initiatives aimed at encouraging the adoption of energy-efficient LED lighting instead of incandescent lighting.

Access the Residential Lighting Fixtures Market Size, Share & Trends Analysis Report By Product (Ceiling, Pendant & Chandeliers, Wall Mounted), By Source, By Distribution Channel, By Region, And Segment Forecasts, 2024 – 2030

Ceiling and wall mounted together held the largest share of the global residential lighting fixture market with over 60% of the total revenue share in 2018. These products illuminate the whole room and make it appear brighter and larger. In addition, availability of a wide range of ceiling and wall mounted fixtures appropriate for different types of homes and décor is anticipated to bode well for the product demand.

Asia Pacific held the leading market share of more than 45% in 2018. Rising number of residential buildings in emerging economies including China, India, and Philippines on account of easy loan assistance by banks for home construction is expected to expand the use of lighting equipment. Additionally, the increasing number of smartphone users in these countries is expected to encourage manufacturers to launch products in their online stores.

Key manufacturers include Koninklijke Philips N.V.; Cree Inc.; General Electric; Hubbell Lighting, Inc.; Acuity Brands, Inc.; Eaton Corporation; Panasonic Corporation; OSRAM Licht AG; Nichia Corporation; and Everlight Electronics Co., Ltd. New product launches is expected to remain a key competitive strategy in the forthcoming years.

Residential Lighting Fixtures Market Report Highlights

The ceiling segment accounted for the largest share of 38.0% in 2023.

LED and OLED product segment is expected to account for a market share of 69.3% in terms of revenue by the end of 2023, owing to excellent energy efficieny of the products.

Middle East and Africa is expected witness the fastest CAGR of 6.2% from 2019 to 2025. The scope for electrification along with government initiatives in African countries including Nigeria, Kenya, and Ethiopia is projected to open new avenues

Asia Pacific led the residential lighting fixture market with more than 45% of revenue share

The online segment is projected to grow at the fastest CAGR of 8.6% over the forecast period.

Order your free sample copy of “Residential Lighting Fixtures Market Report 2024 – 2030, published by Grand View Research

Key Residential Lighting Fixtures Company Insights

Some of the key companies in the residential lighting fixtures market include Koninklijke Philips N.V.; Hubbell Incorporated; Vorlane; Cree Lighting and Kichler Lighting LLC. Vendors in the market are focusing on increasing customer base to gain a competitive edge in the industry. Therefore, key players are taking several strategic initiatives, such as mergers and acquisitions and partnerships with other major companies.

Panasonic Corporation offers a wide range of lighting solutions for residential spaces, focusing on energy efficiency, design aesthetics, and technological innovation.

Key Residential Lighting Fixtures Companies:

The following are the leading companies in the residential lighting fixtures market. These companies collectively hold the largest market share and dictate industry trends.

Koninklijke Philips N.V.
Hubbell Incorporated
Vorlane
Cree Lighting USA LLC.
Kichler Lighting LLC.
Cooper Lighting LLC.
General Electric Company
ACUITY BRANDS, INC
Eaton.
Panasonic Corporation

Recent Developments

In March 2023, Signify acquired Intelligent Lighting Controls, Inc. (ILC), a wired control systems manufacturer. The acquisition is expected to add to Signify’s well established technology and energy-saving solutions in North American market.

About Grand View Research:

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone:-1-415-349-0058

Email: sales@grandviewresearch.com

Embolic Protection Devices Market Report: Regulatory Changes Impacting Industry Growth

The global embolic protection devices market size is expected to reach USD 1.09 billion by 2030, according to a new report by Grand View Research, Inc. The market is estimated to expand at a CAGR of 8.7% from 2024 to 2030. Rising incidences of cardiovascular and neurovascular diseases and growing adoption of minimally invasive diseases are propelling the market growth. Rising demand for technologically advanced embolic devices and increasing healthcare expenditure, resulting in huge funding and investments from multinational companies, are fueling the R&D in the global medical devices industry. This factor is also contributing toward the market growth.

On the other hand, the product failures and recalls may limit the market growth. Low reimbursement for stenting and presence of alternative treatment methods, such as the use of drugs, may also imped the market development. However, factors such as a rise in the number of Trans-catheter Aortic Valve Replacement (TAVR) procedures will support the market expansion.

Access the Embolic Protection Devices Market Size, Share & Trends Analysis Report By Product (Distal Occlusion Devices, Proximal Occlusion Devices, Distal Filters), By Application, By Region, And Segment Forecasts, 2024 – 2030

Embolic Protection Devices Market Report Highlights

Distal filter devices segment emerged as the largest segment owing to high demand for these devices

Neurovascular diseases accounted for the largest share in the application segment owing to the rising cases of neurological disorders

North America led the global embolic protection devices market with the largest share in 2023 and is likely to maintain this trend over the estimated period

Growing adoption of minimally invasive surgeries and increasing demand for novel technologies are facilitating the dominance of this region

The industry in the Asia Pacific is projected to witness swift growth during the forecast period owing to rapidly improving healthcare infrastructure and large target population base

Key Embolic Protection Devices Company Insights

Some of the key companies in the embolic protection devices market include Boston Scientific Corporation, Edwards Lifesciences Corporation, Abbott, Medtronic and others. Vendors in the market are focusing on increasing their customer base to gain a competitive edge in the industry.

Edwards Lifesciences Corporation specializes in manufacturing and development of devices for structural heart diseases and critical care monitoring.

Order your free sample copy of “Embolic Protection Devices Market Report 2024 – 2030, published by Grand View Research

Key Embolic Protection Devices Companies:

The following are the leading companies in the embolic protection devices market. These companies collectively hold the largest market share and dictate industry trends.

Boston Scientific Corporation
Edwards Lifesciences Corporation.
Abbott.
Medtronic
Cardinal Health.
Innovative Cardiovascular Solutions, LLC
Transverse Medical, Inc.
W. L. Gore & Associates, Inc.

Recent Developments

In April 2024, Emboline, Inc., announced the acquisition of SWAT Medical’s Intellectual Property Portfolio of embolic protection. This acquisition is expected to expand Emboline’s existing portfolio of platform technologies to reduce the risk of stroke caused due to the release of embolic debris in the bloodstream during procedures such as Transcatheter Aortic Valve Replacement (TAVR).

About Grand View Research:

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone:-1-415-349-0058

Email: sales@grandviewresearch.com

Enterprise Content Management Market Challenges: Navigating Compliance and Security Risks

The global enterprise content management market size is expected to reach USD 102.01 billion by 2030, according to a study conducted by Grand View Research, Inc., registering a CAGR of 15.1% from 2024 to 2030. Soaring need for securing confidential data is triggering the adoption of enterprise content management (ECM) software. Components of the software include solutions and services such as document management, web content management, records management, document collaboration, and digital rights management. These solutions enable enterprises to reduce their data storage costs and enhance productivity by allowing them to collaborate with employees.

In North America, availability of advanced IT infrastructure and presence of prominent IT giants such as IBM and Microsoft Corporation is poised to drive the adoption of enterprise content management software. Latin American and MEA are projected to witness considerable growth over the coming years owing to growing preference of enterprises for cloud and rising need for IT services by the government sector.

However, vendor dependence and high cost of maintenance are likely to hamper the growth of the market. To overcome this, ECM providers may offer flexibility to enterprises and low-cost maintenance services for gaining credence among organizations.

Access the Enterprise Content Management Market Size, Share & Trends Analysis Report By Component (Software, Services), By Deployment (Cloud And On-Premise), By Enterprise Size, By Application, By Region, And Segment Forecasts, 2024 – 2030

Enterprise Content Management Market Report Highlights

The services segment is expected to post the highest CAGR of over 17.0% during the forecast period due to growing emphasis on periodic maintenance and employee training to enhance operational efficiencies

Cloud-based ECM provides benefits such as high service level, which will drive the growth of the segment over the forecast period. The segment is anticipated to command more than 55.6% % of the overall market revenue by 2030.

The North America enterprise content management market accounted for the largest market revenue share of 41.1% in 2023

Key Enterprise Content Management Company Insights

Some of the key companies in the enterprise content management market include Microsoft Corporation, IBM Corporation, OpenText Corporation, Hyland Software, Inc., Alfresco Software, Inc., and M-Files Corporation. Organizations are focusing on increasing their customer base to gain a competitive edge in the industry. Therefore, key players are taking several strategic initiatives.

Microsoft Corporation provides a comprehensive suite of ECM solutions catering to modern businesses’ diverse needs. From document management to collaboration tools to data protection, Microsoft’s offerings empower organizations to manage their digital content while ensuring security and compliance efficiently.

IBM Corporation provides a full range of Enterprise Content Management (ECM) solutions through IBM FileNet. FileNet offers a centralized place to securely store and organize all your business data, such as documents, emails, images, and more.

Order your free sample copy of “Enterprise Content Management Market Report 2024 – 2030, published by Grand View Research

Key Enterprise Content Management Companies:

The following are the leading companies in the enterprise content management market. These companies collectively hold the largest market share and dictate industry trends.

Microsoft Corporation
IBM Corporation
OpenText Corporation
Hyland Software, Inc.
Alfresco Software, Inc.
M-Files Corporation
Oracle Corporation
Box, Inc.
Laserfiche
DocuWare Corporation

Recent Developments

In January 2024, Microsoft announced the expansion of its Copilot feature, aiming to bring its full power to more people and businesses. This move signifies Microsoft’s commitment to enhancing productivity and collaboration through innovative AI technologies.

About Grand View Research:

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone:-1-415-349-0058

Email: sales@grandviewresearch.com

Cardiac Rehabilitation Market Key Metrics: What Investors Should Know

The global cardiac rehabilitation market size is expected to reach USD 3.3 billion by 2030, at a CAGR of 6.0% according to a new report by Grand View Research, Inc. Rising incidence of lifestyle diseases such as cardiovascular conditions, obesity, and hyperlipidemia is one of the major factors responsible for growth. Technological innovations such as tele-cardiac rehabilitation, which means services provided from a distance using information technologies and telecommunications, are also another major driver of this market.

Furthermore, increase in number of health conscious people is boosting the cardiac rehabilitation market globally. The 2016 American College of Sports Medicine (ACSM) Worldwide Survey of Fitness Trends identified two new trends in the fitness industry, namely, flexibility & mobility rollers and smart phone exercise apps. This shows that people across the globe are becoming more health conscious and are using new products and techniques for better endurance.

Another factor propelling growth is supportive reimbursement pathways such as the Million Hearts initiative and the incentive payment model adopted by the Center for Medicare and Medicaid Services (CMS).

Access the Cardiac Rehabilitation Market Size, Share & Trends Analysis Report By Product (Treadmill, Elliptical Trainer, Stabilization Ball), By End-use (Rehabilitation Centers, Hospitals & Clinics), By Region, And Segment Forecasts, 2024 – 2030

Cardiac Rehabilitation Market Report Highlights

Treadmill dominated the market and accounted for a share of 24.1% in 2023. Regular exercise on treadmill reduces the risk of heart disease, enhances blood circulation and improves heart strength.

Blood pressure monitor is expected to witness the fastest CAGR of 6.8% during the forecast period, owing to rising prevalence of heart disease and CVDs.

The hospitals & clinics segment is projected to grow at the fastest CAGR of 8.5% over the forecast period

North America cardiac rehabilitation market held a dominant share in 2023. The U.S. cardiac rehabilitation dominated the North America market with a share of 88.4% in 2023.

Key Companies & Market Share Insights

Some of the key companies in the cardiac rehabilitation market include Omron Corporation; Ball Dynamics International, LLC; Core Health & Fitness, LLC; Koninklijke Philips N.V. (BioTelemetry Inc); GE Healthcare.

Omron is recognized for its medical devices like blood pressure monitors, digital thermometers, and nebulizers.

Order your free sample copy of “Cardiac Rehabilitation Market Report 2024 – 2030, published by Grand View Research

Key Cardiac Rehabilitation Companies:

The following are the leading companies in the cardiac rehabilitation market. These companies collectively hold the largest market share and dictate industry trends.

Ball Dynamics International, LLC
Core Health & Fitness, LLC
Honeywell International, Inc.
Omron Corporation
Koninklijke Philips N.V. (BioTelemetry Inc)
ICU Medical (Smiths Group)
Halma plc
GE Healthcare
Technogym
Johnson Health Tech

Recent Developments

In April 2024, The Virtual Cardiac Rehabilitation (VCR) Program was launched at Northern Health. The program is expected to help in patient recovery after heart condition, procedure or event.

In January 2024, North Suffolk Cardiology launched Pritikin Intensive Cardiac Rehabilitation Program (ICR). The program at every patient’s visit offers patients detailed lifestyle education and access to cardiac care team in the state of art location.

About Grand View Research:

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058
Email: sales@grandviewresearch.com

Beer Kegs Market Future Outlook: Predictions for 2025 and Beyond

The global beer kegs market size is expected to reach USD 117.3 million by 2030, registering a CAGR of 7.3% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is driven by increasing consumption of beer among young consumers. An analysis conducted by Gallup, Inc., previously known as American Institute of Public Opinion, pertaining to alcohol consumption habits of Americans showed that close to 70.0% of men between the age of 18 and 29 preferred beer over other alcoholic beverages. This trend has continued over the years and has served as a key factor driving the market.

Rising inclination for flavored alcoholic beverages is a trend that is likely to benefit the market. This, along with growing demand for premium products such as craft and draught variants, is fueled by evolving consumer lifestyle and increased per capita income. The rising trend of on-premise sales is also expected to fuel market growth. Kegs help in maintaining the authentic quality and flavor of alcoholic beverages over long durations. Draught beer is mostly served through kegs in order to maintain its pressure, and therefore, the product witnesses greater demand from on-trade sales.

Access the Beer Kegs Market Size, Share & Trends Analysis Report By Material (Steel, Plastic, Others), By Capacity, By Application (Commercial, Residential), By Region, And Segment Forecasts, 2024 – 2030

Steel as a raw material held the dominant share of 84.7% in the market owing to its largescale production in the industry, higher durability, and favorable recycling properties. Steel kegs are used for transportation and storage as it helps in blocking gases and ultraviolet rays, thereby preserving the quality and flavor of beer.

Asia Pacific is expected to exhibit the highest CAGR of 5.1% from 2019 to 2025 on account of increasing production and consumption of beer in the region, majorly driven by countries such as India, China, and Singapore. Moreover, intensifying presence of breweries producing craft and draught beer are adding to product demand. Another factor driving the market is rising number of leading companies investing in sustainable packaging solutions and producing environment-friendly kegs. For instance, the unique DLC kegs produced by Petainer are some of the most eco-friendly variants introduced in Japan.

Beer Kegs Market Report Highlights

Plastic-based beer kegs segment is expected to experience a significant CAGR during the forecast period

The Steel beer kegs segment dominated the market and accounted for a share of 85.3% in 2023

Europe beer kegs market dominated the global industry with a revenue share of 29.5% in 2023. This is attributed to the rising consumption of beer in the region, constant lifestyle changes, the presence of large enterprises from industry operating in the region and ease of availability.

Order your free sample copy of “Beer Kegs Market Report 2024 – 2030, published by Grand View Research

Key Beer Kegs Company Insights

Vendors are focusing on implementing strategies such as mergers and acquisitions to increase product offerings and gain a competitive edge in the industry. Therefore, key players are expanding their production and adopting innovative advancements aiming to fulfil maximum customer needs.

American Keg Company LLC is a U.S.-based company that manufactures high-quality stainless steel kegs. Their skilled craftsmen use food-grade 304 stainless steel.

SCHÄFER Werke GmbH is a German company involved in manufacturing plastics, fabricated metal products, and architectural and structural metals. It focuses on quality, maximum customer satisfaction, and innovation.

Key Beer Kegs Companies:

The following are the leading companies in the beer kegs market. These companies collectively hold the largest market share and dictate industry trends.

American Keg Company (BLEFA GmbH)
NDL Keg Inc
Shinhan Industrial Co, Ltd.
Ningbo BestFriends Beverage Containers Co. Ltd
Blefa GmbH
SCHÄFER Werke GmbH
Ara Partners (Petainer Ltd.)
Ardagh Group S.A.
Julius Kleemann GmbH & Co. KG
The Metal Drum Company

About Grand View Research:

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058
Email: sales@grandviewresearch.com

Therapeutic Drug Monitoring Market Challenges: Overcoming Data Management Issues

The global therapeutic drug monitoring market size is estimated to reach USD 2.32 billion by 2030, expanding at a CAGR of 3.8% from 2024 to 2030, according to a new report by Grand View Research, Inc. Recent technological advancements in the Point-of-Care (PoC) devices hold considerable transformative promises for the personalized predictive and preventive medicine. Therapeutic Drug Monitoring (TDM) forms a foundational part to the devising of personalized treatment plans for patients; and the advent of PoC diagnostic devices that yield quantitative measurements of the drug concentration plays a pivotal role in supporting the development of the precision medicine field in the healthcare sector. However, the broad application of the PoC devices for patient monitoring is still lagging behind. The presence of this untapped opportunity is one of the high impact rendering drivers for the market growth.

The employment of continuous therapeutic drug and metabolite monitoring in the early phase of the medication regimen, administered post-organ transplantation, forms a major application in the areas of critical care medicine and organ transplantation, which is expected to propel the growth of the therapeutic drug monitoring market over the forecast period. In addition, the imposing burden of diseases, such as epilepsy and cancer, the rising government initiatives, and the presence of high-unmet needs are some of the crucial determinants expected to further favor the emergence of this market.

Access the Therapeutic Drug Monitoring Market Size, Share & Trends Analysis Report By Product (Equipment, Consumables), By Drug Class (Antiarrhythmic Drugs), By End Use (Diagnostic Centers), By Region, And Segment Forecasts, 2024 – 2030

Therapeutic Drug Monitoring Market Report Highlights

The consumables segment covered over 65.4% of the market share in 2023 as a consequence of the extensive requirement of the consumables in the research laboratories and due to the repeat purchase of the kits and reagents.

The immunosuppressants segment is expected to grow fastest, with a compounded annual growth rate of 5.3% over the forecast period.

The hospital segment dominated the market share in 2023. In larger hospitals, various underlying technologies are employed to perform immunoassays; these comprise chemiluminescence, nephelometry, colorimetry, and fluorescence, which are available for the testing of a wide ranging drug panel.

The drug monitoring for the immunosuppressants is one of the fastest growing application segments owing to the introduction of novel TDM point-of-care testing devices for the evaluation of the concentration of administered immunosuppressants and the complementary metabolites, in order to achieve a prominent therapeutic effect while preventing drug toxicity events in patients that have undergone transplantations.

Key Therapeutic Drug Monitoring Company Insights

Some of the key companies in the therapeutic drug monitoring market are Abbott, ALPCO, Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., Chromsystems Instruments & Chemicals GmbH, F.Hoffmann-La Roche Ltd., Randox laboratories Ltd, Siemens Healthineers AG., and biomérieux, Inc. Organizations are focusing on increasing customer base to gain a competitive edge in the industry. Therefore, key players are taking several strategic initiatives, such as mergers and acquisitions and partnerships with other major companies.

Abbott, known for its diagnostic technologies, offers a range of products and solutions tailored to monitor drug levels in patients effectively. These include assays and instruments that aid healthcare providers in optimizing medication dosages, ensuring efficacy, and enhancing patient safety across various therapeutic areas.

ALPCO (American Laboratory Products Company) is a player in the therapeutic drug monitoring market, specializing in providing high-quality assays and immunoassay kits. These products are designed to accurately measure drug levels in patient samples, supporting healthcare providers in optimizing therapeutic outcomes and patient management.

Order your free sample copy of “Therapeutic Drug Monitoring Market Report 2024 – 2030, published by Grand View Research

Key Therapeutic Drug Monitoring Companies:

The following are the leading companies in the therapeutic drug monitoring market. These companies collectively hold the largest market share and dictate industry trends.

Abbott
ALPCO
Beckman Coulter, Inc
Bio-Rad Laboratories, Inc
Thermo Fisher Scientific Inc.
Chromsystems Instruments & Chemicals GmbH
F.Hoffmann-La Roche Ltd.
Randox laboratories Ltd
Siemens Healthineers AG.
biomérieux, Inc.

About Grand View Research:

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058
Email: sales@grandviewresearch.com